Can a lighter sedative dose keep patients calm after nasal surgery?

NCT ID NCT07740655

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether a low dose of the sedative remimazolam can prevent emergence agitation—confusion and restlessness during recovery from anesthesia—after nasal surgery. The standard dose can cause excessive sleepiness and brain wave suppression, so researchers want to see if a lower dose works just as well with fewer side effects. Adults aged 18-79 undergoing nasal surgery under sevoflurane anesthesia will receive either a low or standard dose of remimazolam at the end of surgery, and their recovery will be closely monitored.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
remimazolam
What this could lead to
If low-dose remimazolam works as well as the standard dose, it could offer a safer way to prevent post-surgery agitation, reducing excessive sedation and brain activity suppression.
What could go wrong
This is a small, single-center trial, and the lower dose might not be as effective. There's also a risk of allergic reactions or other side effects from the drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMERGENCE AGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jeju National University Hospital

    Jeju City, Jeju-do, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.